Orient EuroPharma Co., Ltd. (TPEX:4120)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
44.50
-0.20 (-0.45%)
At close: Dec 3, 2025
-7.96%
Market Cap3.89B
Revenue (ttm)4.53B
Net Income (ttm)-463.18M
Shares Out86.75M
EPS (ttm)-5.34
PE Ration/a
Forward PEn/a
Dividend1.00 (2.25%)
Ex-Dividend DateJul 7, 2025
Volume6,453
Average Volume24,997
Open44.50
Previous Close44.70
Day's Range44.50 - 44.50
52-Week Range40.05 - 60.70
Beta0.21
RSI34.76
Earnings DateNov 11, 2025

About Orient EuroPharma

Orient EuroPharma Co., Ltd., a pharmaceutical company, develops and manufactures drugs worldwide. Its prescription medicines include cardiovascular, metabolism, neurology, obstetrics and gynecology, respiratory, andrology, immunology, antibiotic, and anti-cancer drugs. The company also provides nutrition and baby care products, such as milk and nutritional supplements under the Karihome, Babecare, and Ostricare brands; and healthcare supplements, such as thermal water for the treatment of oral and periodontal diseases under the Buccotherm name.... [Read more]

Sector Healthcare
Founded 1982
Employees 339
Stock Exchange Taipei Exchange
Ticker Symbol 4120
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.